Post Market Clinical Follow-Up Study - Medical Device KalobaNaso

Clinical trial NCT05960318 · COMPLETED

Trial details

NCT number: NCT05960318
Sponsor: Schwabe Pharma Italia
Status: COMPLETED
Study type: OBSERVATIONAL

Common Cold Nasal Mucosal Inflammation Rhinitis

Start date: 2023-05-08
Primary completion: 2023-07-31
Enrollment: 131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.